| Brianna Lynn Falencki, DPT | |
|
57 W Eagle Rd, Havertown, PA 19083-2234 | |
| (610) 789-9887 | |
| (610) 789-9883 |
| Full Name | Brianna Lynn Falencki |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 57 W Eagle Rd, Havertown, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871969006 | NPI | - | NPPES |
| PT024676 | Other | PA | PROVIDER TAXONOMY - 225100000X |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | PT024676 (Pennsylvania) | Secondary |
| 225100000X | Physical Therapist | PT024676 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brianna Lynn Falencki, DPT 57 W Eagle Rd, Havertown, PA 19083-2234 Ph: (610) 789-9887 | Brianna Lynn Falencki, DPT 57 W Eagle Rd, Havertown, PA 19083-2234 Ph: (610) 789-9887 |
News Archive
People with hypertension, or high blood pressure, play a key role in whether they use medication appropriately to manage their blood pressure.
You're in the supermarket eyeing a basket of sweet, juicy plums. You reach for the conventionally grown stone fruit, then decide to spring the extra $1/pound for its organic cousin. You figure you've just made the healthier decision by choosing the organic product - but new findings from Stanford University cast some doubt on your thinking.
Researchers at the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have developed a new treatment for the pre-stages of cervical cancer, caused by human papilloma virus (HPV) infection.
Researchers in New York City and Guangzhou, China applied the rapidly-developing carbohydrate microarray technology to study an inactivated SARS-coronavirus (SARS-CoV) vaccine and discovered autoimmunogenic activity of this newly identified human viral pathogen.
Exciting advances were made in 2010 in virtually every field of MS research. Progress toward finding new therapies for MS is illustrated by the availability of the first oral disease-modifying therapy for MS. Progress was also made toward finding ways to restore function and improving quality of life and specific MS symptoms through exercise, meditation, rehabilitation and medications, including the first therapy specifically approved to treat a symptom of MS (Ampyra).
› Verified 1 days ago